Efficacy and Safety of Cossac L Tablet in Vasomotor Rhinitis Patients : A Randomized, Double-blind, Placebo-controlled, Phase 3 Clinical Trial

NCT01509209 Phase 3 COMPLETED

The purpose of this study is to evaluate efficacy and safety of Cossac L tablet in the treatment of vasomotor rhinitis

Details

Lead sponsor	Hanmi Pharmaceutical Company Limited
Phase	Phase 3
Status	COMPLETED
Enrolment	137
Start date	2011-05
Completion	2013-04

Conditions

• Vasomotor Rhinitis

Interventions

• Pseudoephedrine / Levocetirizine

Primary outcomes

• TVRSS(Total Vasomotor Rhinitis Symptom Score) — 2week
  the change from baseline in TVRSS

Countries

South Korea